KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nike (NKE) Common Equity (2016 - 2026)

Nike filings provide 18 years of Common Equity readings, the most recent being $14.1 billion for Q1 2026.

  • Quarterly Common Equity rose 0.59% to $14.1 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $14.1 billion through Feb 2026, up 0.59% year-over-year, with the annual reading at $13.2 billion for FY2025, 8.43% down from the prior year.
  • Common Equity hit $14.1 billion in Q1 2026 for Nike, roughly flat from $14.1 billion in the prior quarter.
  • Across five years, Common Equity topped out at $15.8 billion in Q3 2022 and bottomed at $13.2 billion in Q2 2025.
  • Average Common Equity over 5 years is $14.3 billion, with a median of $14.1 billion recorded in 2026.
  • The largest annual shift saw Common Equity grew 24.12% in 2022 before it fell 11.7% in 2023.
  • Nike's Common Equity stood at $15.3 billion in 2022, then dropped by 7.37% to $14.1 billion in 2023, then dropped by 0.77% to $14.0 billion in 2024, then increased by 0.34% to $14.1 billion in 2025, then rose by 0.04% to $14.1 billion in 2026.
  • Per Business Quant, the three most recent readings for NKE's Common Equity are $14.1 billion (Q1 2026), $14.1 billion (Q4 2025), and $13.5 billion (Q3 2025).